SynBioVen: Investment Portfolio & Startup News
SynBioVen
To add a bio or update investment portfolio click update information.
Investment Portfolio


imphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions
imphatec is a British synthetic biology pharmaceutical company developing a customisable-dose subcutaneous implant platform for chronic and long-term conditions. The implants aim to remove the need for manual daily medication by releasing personalised doses over the long term.


HotHouse Therapeutics emerges from stealth with £3m pre-seed led by SynBioVen to develop plant-based drug compounds
HotHouse Therapeutics develops plant-based methods for producing pharmaceutical compounds, using AI and bioengineering to create scalable alternatives to scarce natural ingredients in drug and vaccine supply chains.


Solena Materials raises £5m seed round from biotech investors to develop sustainable protein fibres for apparel
Solena Materials develops bioengineered protein fibres for apparel, using AI and biological manufacturing to create sustainable, high-performance textile materials that replace fossil-based synthetic fabrics.
- 2(12 months)
- synbioven.com
More venture news
- 16 Nov 2026

AlectoAlecto raises a £15m seed round led by Insight Partners to deliver premium legal services for the mass market
SeedLegal - 11 Nov 2026

TendrilsTendrils lands a £23m seed round led by Benchmark to rebuild a computer chip that handles thousands of tasks at once
SeedDeep Tech - 13 Nov 2026

Pro Climbing LeaguePro Climbing League lands a £3m seed round led by Redrice Ventures to bring professional climbing competitions to cities worldwide
SeedConsumer